Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Contact in Context
|
June 30, 2026
Measuring Aztreonam Variations by Process Analytical Technology
Uiyeol Yoon, Ayumi Tarianto, Philip J Almeter, et al.
Contact in Context
|
November 27, 2025
Fourier Transform Near-Infrared Spectrometry Reveals Significant Inter-Lot Variability in Thyrotropin Alfa (Thyrogen<sup>®</sup>) Quality
Uiyeol Yoon, Ayumi Tarianto, Philip J Almeter, et al.
Contact in Context
|
August 25, 2025
Potential Process Control Issues With Abatacept
James T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
Contact in Context
|
May 5, 2025
Near-Infrared Spectrometry as a Tool for Screening Meropenem for Quality
James T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
Contact in Context
|
May 22, 2024
Application of Near-Infrared Spectroscopy for Screening of Chlorothiazide Sodium Vials
James T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
September 27, 2023
Screening for quality with process analytical technology in a health-system pharmacy: A primer
Philip J Almeter, James T Isaacs, Aaron N Hunter, et al.
Contact in Context
|
January 8, 2024
Assessment of Vecuronium Quality Using Near-Infrared Spectrometry
James T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
Contact in Context
|
December 23, 2024
Potential Process Control Issues with Vasopressin
James T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
Journal of Pharmaceutical Innovation
|
June 9, 2022
FDA Approaches in Monitoring Drug Quality, Forces Impacting the Drug Quality, and Recent Alternative Strategies to Assess Quality in the US Drug Supply
Philip J Almeter, James T Isaacs, Aaron N Hunter, et al.
Circulation
|
October 15, 2003
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II
Morteza Naghavi, Peter Libby, Erling Falk, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Contact in Context
|
June 30, 2026
Measuring Aztreonam Variations by Process Analytical Technology
Uiyeol Yoon, Ayumi Tarianto, Philip J Almeter, et al.
Contact in Context
|
November 27, 2025
Fourier Transform Near-Infrared Spectrometry Reveals Significant Inter-Lot Variability in Thyrotropin Alfa (Thyrogen<sup>®</sup>) Quality
Uiyeol Yoon, Ayumi Tarianto, Philip J Almeter, et al.
Contact in Context
|
August 25, 2025
Potential Process Control Issues With Abatacept
James T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
Contact in Context
|
May 5, 2025
Near-Infrared Spectrometry as a Tool for Screening Meropenem for Quality
James T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
Contact in Context
|
May 22, 2024
Application of Near-Infrared Spectroscopy for Screening of Chlorothiazide Sodium Vials
James T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
September 27, 2023
Screening for quality with process analytical technology in a health-system pharmacy: A primer
Philip J Almeter, James T Isaacs, Aaron N Hunter, et al.
Contact in Context
|
January 8, 2024
Assessment of Vecuronium Quality Using Near-Infrared Spectrometry
James T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
Contact in Context
|
December 23, 2024
Potential Process Control Issues with Vasopressin
James T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
Journal of Pharmaceutical Innovation
|
June 9, 2022
FDA Approaches in Monitoring Drug Quality, Forces Impacting the Drug Quality, and Recent Alternative Strategies to Assess Quality in the US Drug Supply
Philip J Almeter, James T Isaacs, Aaron N Hunter, et al.
Circulation
|
October 15, 2003
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II
Morteza Naghavi, Peter Libby, Erling Falk, et al.
Page
of 6